Page 3 - Pfizer

Pfizer agrees to pay $93 million to settle Lipitor antitrust lawsuit

Attorneys for Lipitor purchasers including Rochester Drug Co-Operative Inc and Puerto Rico's Drogueria Betances LLC disclosed the agreement in a filing on Wednesday in US court in Trenton, New Jersey

Pfizer agrees to pay $93 million to settle Lipitor drug antitrust lawsuit

Pfizer introduced Lipitor in 1997, and the drug drove more than $130 billion in sales during its first 14 years on the market

Glenmark, Pfizer launch Abrocitinib in India for Atopic Dermatitis

The prevalence of atopic dermatitis in India has risen over the past three decades, with approximately 5.9 per cent of adults affected, of which 4.4 per cent suffer from a severe form of the disease

Pfizer posts surprise 4th quarter profit, but key products miss on sales

The New York-based drugmaker earned 10 cents per share on an adjusted basis for the fourth quarter. Analysts on average had expected a loss of 22 cents per share, according to LSEG data

Pfizer Q2 results: Net profit declines 52% at Rs 149 cr, revenue slips 9.8%

Drug firm Pfizer Ltd on Saturday reported 52.11 per cent decline in net profit at Rs 148.96 crore for the second quarter ended September 2023. The company had logged a net profit of Rs 311.07 crore in July-September period a year ago, according to a regulatory filing by Pfizer. Revenue from operations declined 9.76 per cent to Rs 575.21 crore in the quarter as against Rs 637.47 crore in the year-ago period. Total expense was at Rs 410.76 crore, down 5.66 per cent. Total income was at Rs 611.28 crore in September quarter 2023-24, down 7.62 per cent.

Moderna's Covid-19 vaccine protects against new variants, finds early study

Covid vaccine partners Pfizer Inc. and BioNTech SE are also developing updated shots, as is Novavax Inc. The drugmakers have been testing and making new updates as the virus has evolved

Pfizer misses revenue estimates as Covid-19 product sales decline

The company has said it expects 2023 to be a low point for COVID product sales following strong demand at the peak of the pandemic before a potential return to growth in 2024

Tornado damage to Pfizer plant unlikely to cause supply shortages: US FDA

Most of the destruction from a tornado that tore through eastern North Carolina on Wednesday and struck a large Pfizer pharmaceutical plant affected its storage facility, rather than its medicine production areas, the company said on Friday. The drugmaker's ability to salvage production equipment and other essential materials could mitigate what experts feared would be a major blow to an already strained system as the United States grapples with existing drug shortages. We do not expect there to be any immediate significant impacts on supply given the products are currently at hospitals and in the distribution system, US Food and Drug Administration Commissioner Robert Califf said on Friday. An EF3 tornado touched down on Wednesday near Rocky Mount, ripping the roof off a Pfizer factory responsible for producing nearly 25 per cent of the American pharmaceutical giant's sterile injectable medicines used in US hospitals, according to the drugmaker. Pfizer said on Friday that a wareho

Pfizer's proposed $43 bn takeover of Seagen faces EU investigation

If the takeover goes through, Seagen's portfolio would double Pfizer's pipeline of early-stage experimental cancer therapies, Pfizer has said

US: 2 Indian-origin men charged with insider trading with Pfizer Covid meds

Two Indian-origin people, including a former Pfizer employee, have been charged with insider trading by federal authorities for their scheme to reap illicit profits by trading on information about the results of a COVID-19 medicine's clinical trials by the pharmaceutical giant. Amit Dagar, a former Pfizer employee, and his close friend and business partner Atul Bhiwapurkar were charged on Thursday by the US Securities and Exchange Commission (SEC) for their scheme to reap illicit profits through insider trading. In a parallel action, the US Attorney's Office for the Southern District of New York also announced criminal charges against the duo. Dagar, 44, of Hillsborough, New Jersey, was arrested on Thursday and was charged with four counts of securities fraud, each of which carries a maximum sentence of 20 years in prison, and one count of conspiracy to commit securities fraud, carrying a maximum sentence of five years in prison. Bhiwapurkar, 45, of Milpitas, California, was also .

Eli Lilly's 'triple G' anti-obesity drug leads to 24% weight loss in trial

The pharma company published the results of phase two of the clinical trial of Retatrutide, showing impressive weight loss and regulation of blood sugar levels in undertrials

Pfizer to discontinue development of obesity drug due to side effects

Pfizer has been developing treatments to target weight loss in diabetes and obesity patients, as it races to target a market estimated to reach $100 billion by the end the of decade

'Govt kept same rules for Indian, foreign cos while getting Covid vaccines'

Foreign-made vaccines were not procured during the Covid pandemic as the firms were demanding indemnity, which was not made available to Indian vaccine manufacturers, Union Health Minister Mansukh Mandaviya has said, asserting that the "same rule applies for all". He also said that it was wrong to suggest that India stopped foreign made vaccines like that made by Moderna and Pfizer from coming to India. "We may have certain requirements and strengths and other countries may have some other strengths and needs. It is wrong to say that India stopped any country from coming to India.When they applied with required data, we gave them emergency use approvals just like we gave to Indian companies," Mandaviya said in an exclusive interview to PTI recently. However, their demands for indemnification and sovereign immunity waivers were a major impediment and eventually the government did not go ahead with it, the minister stated. "At that time, Sputnik vaccine was also there and so were Ind

Pfizer and GSK to battle for share of new RSV vaccine market: Report

US drugmaker Pfizers and British pharma major GSK are likely to face significant competition in the respiratory syncytial virus (RSV) vaccine market, according to a report on Tuesday

BioNTech faces several lawsuits in Germany over Covid vaccine side effects

German drug company BioNTech is facing hundreds of lawsuits, worth one million euros, in country for alleged health damage due to its Covid-19 vaccine, co-developed with American pharma giant Pfizer

Stocks to Watch today, May 19: ITC, Thomas Cook, Zomato, Nexus REIT, IndiGo

Stocks to Watch on Friday: ITC Limited reported a 21.4 per cent YoY growth in standalone net profit at Rs 5,086.9 crore for the March quarter

Pfizer suspends sale of three antibiotics in India over technical issues

Investigating matter with contract manufacturer Astral Steritech, says pharma firm

Pfizer suspends sale, use of some products in India over quality concerns

Stockists have been asked not to sell, distribute, or use the products until further notice from Pfizer

Pfizer consolidated net profit rises 3% to Rs 130 crore in March quarter

The company said its board recommended a final dividend of Rs 35 per share of Rs 10 each

Pfizer pouring windfall profits from Covid-19 vaccine into cancer battle

The U.S. government will end the COVID Public Health Emergency on Thursday that allowed millions of Americans to receive vaccines, tests and treatments at no cost